Enoch, PharmD BCPS BCCCP
@ecpharmd.bsky.social
🙏🏽🇭🇹👨🏽💻 | CCM | 📈
“confidence is quiet” - unknown
“confidence is quiet” - unknown
Reposted by Enoch, PharmD BCPS BCCCP
Learn how "The Caregiver Pathway" intervention can reduce Post-Intensive Care Syndrome-Family symptoms for caregivers of surviving ICU patients in this Critical Care Medicine article: buff.ly/r8xn4DL
#SCCM
#SCCM
March 16, 2025 at 1:00 PM
Learn how "The Caregiver Pathway" intervention can reduce Post-Intensive Care Syndrome-Family symptoms for caregivers of surviving ICU patients in this Critical Care Medicine article: buff.ly/r8xn4DL
#SCCM
#SCCM
Reposted by Enoch, PharmD BCPS BCCCP
🚨First gen cephs for the treatment of UTIs 🙌🏼 cefazolin resulted in similar 30-day clinical success 🆚 ceftriaxone in a 🆕 VA cohort study❗️Antimicrobial stewardship 🤝 local antibiogram 💙 #IDSky
🔗: bmcinfectdis.biomedcentral.com/articles/10....
🔗: bmcinfectdis.biomedcentral.com/articles/10....
A comparison of empiric therapy with cefazolin versus ceftriaxone for patients with complicated urinary tract infections in a tertiary care veterans affairs medical center - BMC Infectious Diseases
Background Data are limited regarding use of narrow-spectrum agents for the treatment of complicated urinary tract infections (cUTIs). We sought to evaluate cefazolin compared with ceftriaxone for the...
bmcinfectdis.biomedcentral.com
March 15, 2025 at 2:44 AM
🚨First gen cephs for the treatment of UTIs 🙌🏼 cefazolin resulted in similar 30-day clinical success 🆚 ceftriaxone in a 🆕 VA cohort study❗️Antimicrobial stewardship 🤝 local antibiogram 💙 #IDSky
🔗: bmcinfectdis.biomedcentral.com/articles/10....
🔗: bmcinfectdis.biomedcentral.com/articles/10....